Analysts See Pipeline Catalysts Driving Teva Pharmaceutical Industries Limited (TEVA)’s 2026 Growth Despite Revenue Headwinds
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best healthcare stocks to buy for 2026.
Insider Monkey Blog
Analyst Upgrades Signal Renewed Growth Cycle for Edwards Lifesciences Corporation (EW)
Edwards Lifesciences Corporation (NYSE:EW) is one of the best healthcare stocks to buy for 2026.
Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the best healthcare stocks to buy for 2026.
CVS Health Corporation (CVS) Positioned for Long-Term Growth Amid Policy Shifts
CVS Health Corporation (NYSE:CVS) is one of the best healthcare stocks to buy for 2026.
AbbVie Inc. (ABBV) Balances Analyst Caution with Pipeline Progress and Long-Term Growth
AbbVie Inc. (NYSE:ABBV) is one of the best healthcare stocks to buy for 2026. On January 28, Goldman Sachs reaffirmed its Neutral rating and $223 price target on AbbVie Inc.
Eli Lilly and Company (LLY) Expands U.S. Manufacturing and Advances Breakthrough Therapies
Eli Lilly and Company (NYSE:LLY) is one of the best healthcare stocks to buy for 2026. On January 29, Reuters reported that U.S.
Why These Energy Stocks are Gaining This Week
The US energy sector came to a halt as an Arctic blast with frigid temperatures swept across the country this week, leading to a significant fall in the country’s oil and gas...
10 Stocks with Huge Growth Potential According to the Media
The US economic outlook remaining positive is the catalyst behind equity markets powering to record highs amid valuation concerns.
Piper Sandler Updates Its Outlook on Visa (V) Shares
Over time, the economy grows alongside gross domestic product. As activity expands, spending tends to follow.
Jim Cramer on Starbucks: “I Think This Turn Is Solid and Long-Lasting”
Starbucks Corporation (NASDAQ:SBUX) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer on Lithium Americas: “We’re Going to Say It’s Too Speculative for Me”
Lithium Americas Corp. (NYSE:LAC) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer in Intuit: “I Think It Should Do Better”
Intuit Inc. (NASDAQ:INTU) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer on Energy Transfer: “Very Inexpensive Stock, Great Pipeline Company”
Energy Transfer LP (NYSE:ET) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer on Robinhood: “It Is a Buy”
Robinhood Markets, Inc. (NASDAQ:HOOD) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer Highlights Teva Pharmaceutical’s Growth Under CEO Richard Francis
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer Notes That Levi’s “Suffered From President Trump’s Trade War”
Levi Strauss & Co. (NYSE:LEVI) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer Highlights ServiceNow’s Buyback Plans and Says It Delivered a “Pretty Darn Good Quarter”
ServiceNow, Inc. (NYSE:NOW) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer Says “I Think That You Gotta Pull the Trigger on Netflix”
Netflix, Inc. (NASDAQ:NFLX) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer on International Business Machines: “Inexpensive Stock Even Here”
International Business Machines Corporation (NYSE:IBM) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer Says Tesla’s Robots and Robotaxi Progress Are the Real Drivers Behind the Stock’s After-Hours Move
Tesla, Inc. (NASDAQ:TSLA) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer on Meta: “They Got the Memo”
Meta Platforms, Inc. (NASDAQ:META) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer on Microsoft’s Capex Budget: “That’s Not What the Market Wants”
Microsoft Corporation (NASDAQ:MSFT) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer GE Vernova Has “Visibility on the Earnings to the 2030s”
GE Vernova Inc. (NYSE:GEV) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer Shows Bullish Sentiment Toward Sandisk
Sandisk Corporation (NASDAQ:SNDK) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer Says “Micron Has Absurd Pricing Power”
Micron Technology, Inc. (NASDAQ:MU) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer Highlights Why He Likes Agnico Eagle
Agnico Eagle Mines Limited (NYSE:AEM) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer on Texas Pacific: “My Problem Is, in the End, It Is Going to Trade”
Texas Pacific Land Corporation (NYSE:TPL) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Jim Cramer on DraftKings: “It’s in the Wilderness”
DraftKings Inc. (NASDAQ:DKNG) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages.
Cantor Fitzgerald Sees Structural Tailwinds Supporting Mastercard’s (MA) Long-Term Growth
On January 27, Cantor Fitzgerald initiated coverage of Mastercard Incorporated (NYSE:MA) with an Overweight rating and a $650 price target.
Eli Lilly (LLY) Taps Gene-Editing Technology to Target Hearing Loss, Reuters Reports
According to a report by Reuters, Eli Lilly and Company (NYSE:LLY) has signed an agreement worth up to $1.12 billion with Seamless Therapeutics.
Walmart’s (WMT) Technology Push Draws Optimism From Tigress Financial
On January 23, Tigress Financial raised its price target on Walmart Inc. (NASDAQ:WMT) to $135 from $130 while maintaining a Buy rating.
TD Cowen Highlights Steady Execution at Union Pacific (UNP) After Q4 Results
On January 28, TD Cowen trimmed its price target on Union Pacific Corporation (NYSE:UNP) to $255 from $257 while maintaining a Buy rating.
Exxon’s (XOM) Relative Valuation Comes into Focus at BofA
On January 28, BofA lifted its price target on Exxon Mobil Corporation (NYSE:XOM) to $135 from $129 while maintaining a Neutral rating.
12 Tech Stocks with the Biggest Upside Potential
Technology stocks remain volatile amid rising AI adoption.
Citi Sees a More Supportive Backdrop Forming for AbbVie (ABBV) and Biopharma
On January 27, Citi modestly cut its price target on AbbVie Inc. (NYSE:ABBV) to $230 from $235 while leaving its Neutral rating unchanged.
Cantor Fitzgerald Sees Deal Activity and Pipeline Progress as Key for Merck’s (MRK) Next Phase
On January 27, Cantor Fitzgerald boosted its price target on Merck & Co., Inc. (NYSE:MRK) to $116 from $83 but kept its Neutral stance on the stock.
TD Cowen Sees a Slower Recovery Path Taking Shape at Procter & Gamble (PG)
On January 27, TD Cowen downgraded The Procter & Gamble Company (NYSE:PG) to Hold from Buy while raising its price target to $156 from $150.
Argus Sees Long-Term Growth Tailwinds Building at NextEra Energy (NEE)
On January 28, Argus raised its price target on NextEra Energy, Inc. (NYSE:NEE) to $92 from $90 and reaffirmed its Buy rating following the company’s Q4 earnings beat.
Jefferies Sees Further Upside as Caterpillar’s (CAT) Broader Portfolio Gains Traction
On January 27, Jefferies raised its price target on Caterpillar Inc. (NYSE:CAT) to $750 from $700 and reiterated a Buy rating on the stock.
PepsiCo (PEP) Enters a New Strategic Chapter as BNP Paribas Highlights Earnings Upside
On January 16, BNP Paribas raised its rating on PepsiCo, Inc. (NASDAQ:PEP) to Outperform from Neutral. It set a $179 price target on the stock.
H.C. Wainwright is Bullish on TRX Gold Corporation (TRX)
On January 16, 2026, TheFly reported that H.C. Wainwright kept its Buy rating. It boosted its price objective for TRX Gold Corporation (NYSE:TRX) from $1.40 to $1.50.
Roth Capital is Bullish on GoldMining Inc. (GLDG)
On January 7, 2026, TheFly reported that Roth Capital reaffirmed its Buy recommendation. It lifted GoldMining Inc. (NYSE:GLDG)’s price objective to $2.80 from $2.60.
New Found Gold Corp. (NFGC) Completes Key Milestone at Queensway Gold Project by Entering into Phase 1 EPCM Contract
On January 26, 2026, New Found Gold Corp. (NYSE:NFGC) entered into a Phase 1 EPCM contract with WSP Canada Inc.
Caledonia Mining Corporation Plc (CMCL) Raises $150 Million for Zimbabwe’s Gold Mine in a Rare International Capital Raise
Caledonia Mining Corporation Plc (NYSE:CMCL) reportedly obtained $150 million through a seven-year convertible bond sale to finance the construction of its Bilboes project, which...
Seabridge Gold Inc. (SA) Released a 2025 Year-End Report
Seabridge Gold Inc. (NYSE:SA) released a 2025 year-end report on operations, exploration, and corporate initiatives on December 18, 2025.
Osisko Development Corp. (ODV) Announces $125M Bought Deal Offering
On January 27, 2026, TheFly reported that Osisko Development Corp. (NYSE:ODV) announced a $125 million bought deal financing on behalf of a syndicate.
BofA is Bullish on Aura Minerals Inc. (AUGO)
On January 19, 2026, TheFly reported that BofA reaffirmed its Buy rating and lifted its price objective for Aura Minerals Inc. (NASDAQ:AUGO) from $55.50 to $70.
Dakota Gold Corp. (DC) Announces 2026 Plans for the Richmond Hill and Maitland Gold Projects
Dakota Gold Corp. (NYSE:DC) released new drill results and plans for the Richmond Hill and Maitland projects on January 13, 2026.
i-80 Gold Corp. (IAUX) Announces New High-Grade Assay Results
i-80 Gold Corp. (NYSE:IAUX) released fresh high-grade test findings from its 2025 drilling program at Nevada’s Granite Creek Underground Project on January 20, 2026.
Hedge Fund Resource Center
